In vitro synergistic effects of baicalin with oxytetracycline and tetracycline against Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 6, 2011, Pages 1298-1300

  Novy, Pavel ^a   Urban, Jan ^b   Leuner, Olga ^a   Vadlejch, Jaroslav ^a   Kokoska, Ladislav ^a  

^a CZECH UNIVERSITY OF LIFE SCIENCES PRAGUE   (Czech Republic)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

Antimicrobial agents; Flavonoid; Staphylococci; Synergy

Indexed keywords

BAICALIN; OXYTETRACYCLINE; TETRACYCLINE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BROTH DILUTION; DRUG POTENTIATION; DRUG STRUCTURE; IC 50; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; DRUG SYNERGISM; FLAVONOIDS; HUMANS; MICROBIAL SENSITIVITY TESTS; OXYTETRACYCLINE; SCUTELLARIA; STAPHYLOCOCCUS AUREUS; TETRACYCLINE;

EID: 79956018866     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr108     Document Type: Article

References (10)

1. Ruhe JJ, Monson T, Bradsher RW et al. Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature. Clin Infect Dis 2005; 40: 1429-34.
2. Gibbons S. Phytochemicals for bacterial resistance-strengths, weaknesses and opportunities. Planta Med 2008; 74: 594-602.
3. Li-Weber M. New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents wogonin, baicalein and baicalin. Cancer Treat Rev 2009; 35: 57-68.
4. Liu IX, Durham DG, Richards RME. Baicalin synergy with b-lactam antibiotics against methicillin-resistant Staphylococcus aureus and other b-lactam-resistant strains of S. aureus. J Pharm Pharmacol 2000; 52: 361-6.
5. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically- Eighth Edition: Approved Standard M07-A8. CLSI, Wayne, PA, USA, 2009.
6. European Committee for Antimicrobial Susceptibility Testing. Terminology relating to methods for determination of susceptibility bacteria to antimicrobial agents. Clin Microbiol Infect 2000; 6: 503-8.
7. Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003; 52: 1.
8. Fujita M, Shiota S, Kuroda T et al. Remarkable synergies between baicalein and tetracycline, and baicalein and b-lactams against methicillin-resistant Staphylococcus aureus. Microbiol Immunol 2005; 49: 391-6.
9. Zhao WH, Hu ZQ, Okubo S et al. Mechanism of synergy between epigallocatechin-gallate and b-lactams against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2001; 45: 1737-42.
10. Chang P-C, Li H-Y, Tang H-J et al. In vitro synergy of baicalein and gentamycin against vancomycin-resistant Enterococcus. J Microbiol Immunol Infect 2007; 40: 56-61.